These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31934800)
1. Precision medicine and gut dysbiosis. Harris C; Kim PT; Waterhouse D; Feng Z; Niergarth J; Lee CH Healthc Manage Forum; 2020 May; 33(3):107-110. PubMed ID: 31934800 [No Abstract] [Full Text] [Related]
2. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585 [TBL] [Abstract][Full Text] [Related]
3. Identification and engraftment of new bacterial strains by shotgun metagenomic sequence analysis in patients with recurrent Clostridioides difficile infection before and after fecal microbiota transplantation and in healthy human subjects. Verma S; Dutta SK; Firnberg E; Phillips L; Vinayek R; Nair PP PLoS One; 2021; 16(7):e0251590. PubMed ID: 34252073 [TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation for treatment of patients with recurrent Voth E; Khanna S Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848 [TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. Rao K; Safdar N J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412 [TBL] [Abstract][Full Text] [Related]
7. Pros and cons: Is faecal microbiota transplantation a safe and efficient treatment option for gut dysbiosis? Marrs T; Walter J Allergy; 2021 Jul; 76(7):2312-2317. PubMed ID: 33483999 [TBL] [Abstract][Full Text] [Related]
8. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection. Zuo T; Wong SH; Cheung CP; Lam K; Lui R; Cheung K; Zhang F; Tang W; Ching JYL; Wu JCY; Chan PKS; Sung JJY; Yu J; Chan FKL; Ng SC Nat Commun; 2018 Sep; 9(1):3663. PubMed ID: 30202057 [TBL] [Abstract][Full Text] [Related]
9. Fecal Microbiota Therapy With a Focus on Clostridium difficile Infection. Brandt LJ Psychosom Med; 2017 Oct; 79(8):868-873. PubMed ID: 28976455 [TBL] [Abstract][Full Text] [Related]
10. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation. Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ mBio; 2016 Dec; 7(6):. PubMed ID: 27999162 [TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota Transplantation for the Management of Paknikar R; Pekow J Surg Infect (Larchmt); 2018; 19(8):785-791. PubMed ID: 30300561 [TBL] [Abstract][Full Text] [Related]
13. The Super-Donor Phenomenon in Fecal Microbiota Transplantation. Wilson BC; Vatanen T; Cutfield WS; O'Sullivan JM Front Cell Infect Microbiol; 2019; 9():2. PubMed ID: 30719428 [TBL] [Abstract][Full Text] [Related]
14. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway. Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484 [TBL] [Abstract][Full Text] [Related]